Brought to you by 
Catalent closes $500mm senior note sale
27 Jun 2019
Executive Summary
Catalent Inc. privately sold $500mm in aggregate principal amount of 5% senior unsecured notes due 2027 priced at par. The company will use the proceeds to pay off outstanding borrowings and related fees under term loans from existing senior secured credit facilities.
Deal Industry
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
- Services
-
Pharmaceuticals
- OTC, Consumer
-
Drug Delivery
- Controlled Release
- Macromolecule
-
Biotechnology
- Drug Discovery Tools
- Large Molecule
- Synthesis Technologies, Production Processes
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Catalent closes $500mm senior note sale
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice